Business context and reporting period
The filing is a Form 10-Q for the quarter ended December 31, 2012, covering Prestige Brands Holdings, Inc. (the registrant named in the filing; the request identifies Prestige Consumer Healthcare Inc.). The company markets and distributes over-the-counter healthcare and household cleaning products, primarily in the U.S. and Canada. Results are unaudited and cover the three and nine months ended December 31, 2012; the fiscal year ends March 31.
Financial performance and condition
Amounts below are in millions of dollars except per-share data. Comparisons are with the corresponding 2011 periods.
| Metric | Three months 2012 | Three months 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Total revenues | $160.2 | $106.3 | $469.1 | $307.1 |
| Gross profit | $85.0 | $55.1 | $259.1 | $158.9 |
| Gross margin | 53.0% | 51.9% | 55.2% | 51.7% |
| Operating income | $46.7 | $23.6 | $141.7 | $80.3 |
| Net income | $12.3 | $9.5 | $46.2 | $37.2 |
| Diluted EPS | $0.24 | $0.19 | $0.90 | $0.73 |
| Net cash from operating activities | Not separately stated | Not separately stated | $100.9 | $48.0 |
Revenue increased 50.8% for the quarter and 52.8% for the nine-month period. Operating margins were approximately 29.2% and 30.2%, respectively, versus 22.2% and 26.1% in the comparable periods. Nine-month net margin was approximately 9.8%, down from 12.1%, as substantially higher interest expense absorbed part of the operating improvement. Interest expense was $26.7 million for the quarter and $66.2 million for nine months, compared with $8.1 million and $25.0 million.
At December 31, 2012, cash was $10.4 million, current assets $151.2 million, and current liabilities $88.8 million. The current ratio was approximately 1.7, compared with approximately 2.3 at March 31, 2012. Principal debt was $1,007.5 million ($1,000.3 million net of discount), down from $1,135.0 million principal at March 31. The company had $33.8 million of available borrowing capacity under its $75 million ABL revolver. Nine-month capital expenditures were $8.9 million. Operating cash flow of $100.9 million, investing cash flow of $12.6 million, and financing cash outflow of $122.0 million resulted in cash declining by $8.6 million.
Material changes versus prior comparable periods
- Growth was principally acquisition-driven: GSK brands contributed $56.9 million of revenue and $8.7 million of net income in the quarter, and $159.9 million of revenue and $18.4 million of net income over nine months. The acquisition makes year-over-year comparisons less like-for-like.
- OTC Healthcare revenue rose 63.7% in the quarter and 71.4% over nine months. Household Cleaning revenue declined 0.7% and 8.2%, respectively; management cited weaker Comet and Spic and Span demand and higher promotional allowances.
- Gross margin improved, largely reflecting the acquired GSK product mix. Nine-month Household Cleaning gross profit fell 22.0%, while OTC Healthcare gross profit increased 75.9%.
- Advertising and promotion expense increased to $23.5 million for the quarter and $67.4 million for nine months, supporting acquired and legacy brands. Nine-month G&A rose to $40.1 million from $32.4 million, including compensation, transition-service, relocation and other costs, partly offset by lower prior-year acquisition and legal costs.
- Phazyme was sold on October 31, 2012 for $22.3 million total proceeds; $21.7 million was received during the period and the balance in January 2013. Proceeds were used to repay debt, with no significant gain or loss recorded.
Outlook, commentary, risks and unusual items
- No revenue, earnings or full-year operating guidance is provided. Management estimated a 38.9% effective tax rate for the remaining fiscal 2013 quarter, excluding discrete items, and anticipated covenant compliance in the ensuing year.
- The company reported compliance with its debt covenants at December 31, 2012. Debt agreements impose leverage, interest-coverage and fixed-charge tests and restrict certain actions. Scheduled term-loan principal payments were not required before maturity following voluntary repayments.
- Debt repayment triggered $7.7 million of noncash accelerated amortization of financing costs and debt discount in quarterly interest expense; $3.0 million related to prior quarters. Management said the timing adjustment was not material to prior periods or estimated full-year results and did not affect cash flows.
- Interest-rate exposure is material: $507.5 million of debt was variable-rate. A one-percentage-point rate increase was estimated to reduce pretax earnings and cash flows by approximately $1.4 million for the quarter and $4.4 million for nine months, holding other factors constant.
- Key risks include high debt and interest costs, competition and pricing pressure, dependence on major retailers (Walmart represented 15.3% of quarterly gross revenue and 23.6% of receivables), reliance on third-party manufacturers, and distribution-center disruption. A manufacturer serving an international product line had filed for bankruptcy; shortages and higher supply costs had adversely affected the business, and replacement supply was being arranged.
- Goodwill and intangible assets totaled approximately $1.54 billion, a substantial share of assets. No impairment was recorded, but management noted that weaker sales or margins, competition, changing preferences, higher rates or reduced advertising support could prompt future impairment.
- The filing describes corrections to prior-period consolidating statements and classifications; management concluded these did not affect consolidated financial statements and were not material to them. Management reported disclosure controls effective and no material quarterly change in internal control over financial reporting.
Important facts for investors to verify
- Separate acquisition-driven growth from comparable or organic performance, including the trend in legacy cough-and-cold products and Household Cleaning brands.
- Track debt reduction, variable-rate exposure, interest expense, revolver availability and ongoing covenant headroom.
- Assess cash conversion and working-capital movements, particularly receivables, marketing accruals and inventory.
- Monitor the bankrupt manufacturer’s supply transition, product availability and resulting costs, as well as customer and distribution concentration.
- Review the noncash debt-cost acceleration and the company’s stated immateriality assessment, and monitor goodwill and intangible-asset impairment assumptions.